KR101263963B1 - 항바이러스 및 면역자극 해산 어류 오일 조성물 - Google Patents

항바이러스 및 면역자극 해산 어류 오일 조성물 Download PDF

Info

Publication number
KR101263963B1
KR101263963B1 KR1020077014591A KR20077014591A KR101263963B1 KR 101263963 B1 KR101263963 B1 KR 101263963B1 KR 1020077014591 A KR1020077014591 A KR 1020077014591A KR 20077014591 A KR20077014591 A KR 20077014591A KR 101263963 B1 KR101263963 B1 KR 101263963B1
Authority
KR
South Korea
Prior art keywords
mass
acid ester
sin
polyunsaturated fatty
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077014591A
Other languages
English (en)
Korean (ko)
Other versions
KR20070086689A (ko
Inventor
제노 스질베레키
안드레아 제드나코비트스
엘논 콜테이
줄러 올반
카타린 비로
Original Assignee
신넥스 무사키 훼레스테 에쉬 타나차도 케이에프티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 신넥스 무사키 훼레스테 에쉬 타나차도 케이에프티 filed Critical 신넥스 무사키 훼레스테 에쉬 타나차도 케이에프티
Publication of KR20070086689A publication Critical patent/KR20070086689A/ko
Application granted granted Critical
Publication of KR101263963B1 publication Critical patent/KR101263963B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020077014591A 2004-12-03 2005-11-15 항바이러스 및 면역자극 해산 어류 오일 조성물 Expired - Fee Related KR101263963B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0402490A HU227588B1 (hu) 2004-12-03 2004-12-03 Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
HUP0402490 2004-12-03

Publications (2)

Publication Number Publication Date
KR20070086689A KR20070086689A (ko) 2007-08-27
KR101263963B1 true KR101263963B1 (ko) 2013-05-13

Family

ID=89985663

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077014591A Expired - Fee Related KR101263963B1 (ko) 2004-12-03 2005-11-15 항바이러스 및 면역자극 해산 어류 오일 조성물

Country Status (13)

Country Link
US (1) US9381213B2 (https=)
EP (1) EP1830861B1 (https=)
JP (1) JP4976307B2 (https=)
KR (1) KR101263963B1 (https=)
CN (1) CN101068540B (https=)
AT (1) ATE429236T1 (https=)
CA (1) CA2588195C (https=)
DE (1) DE602005014142D1 (https=)
DK (1) DK1830861T3 (https=)
ES (1) ES2326091T3 (https=)
HU (1) HU227588B1 (https=)
PL (1) PL1830861T3 (https=)
WO (1) WO2006059169A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1800675T3 (da) 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
SG10201605794PA (en) * 2009-04-29 2016-09-29 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
JP2012149000A (ja) * 2011-01-18 2012-08-09 Junsei Educational Institution 免疫賦活剤ならびにこれを含む食品および医薬組成物
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
AU2021324673B2 (en) * 2020-08-10 2025-07-24 Houn Simon Hsia Compositions and methods for treating viral infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
EP0891771A1 (en) * 1997-07-08 1999-01-20 Health Now, Inc. Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
AT412758B (de) * 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
ATE555782T1 (de) * 2002-03-08 2012-05-15 Philera New Zealand Ltd Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz

Also Published As

Publication number Publication date
DK1830861T3 (da) 2009-07-27
JP4976307B2 (ja) 2012-07-18
PL1830861T3 (pl) 2009-09-30
HU0402490D0 (en) 2005-02-28
KR20070086689A (ko) 2007-08-27
EP1830861A2 (en) 2007-09-12
EP1830861B1 (en) 2009-04-22
CN101068540A (zh) 2007-11-07
ATE429236T1 (de) 2009-05-15
WO2006059169A3 (en) 2007-02-22
ES2326091T3 (es) 2009-09-30
US9381213B2 (en) 2016-07-05
HU227588B1 (hu) 2011-09-28
DE602005014142D1 (de) 2009-06-04
JP2008521877A (ja) 2008-06-26
HUP0402490A2 (en) 2009-04-28
CN101068540B (zh) 2013-01-09
CA2588195C (en) 2014-12-23
CA2588195A1 (en) 2006-06-08
US20080131519A1 (en) 2008-06-05
WO2006059169A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
Isaacs et al. Antiviral and antibacterial lipids in human milk and infant formula feeds.
AU619797B2 (en) Antiviral and antibacterial activity of fatty acids and monoglycerides
EP0374390B1 (en) Whey protein composition, a method for producing it and application of the whey protein composition
ES2643862T3 (es) Composiciones antimicrobianas que contienen ácidos grasos libres
ES2219871T3 (es) Procedimiento y composiciones que sirven para limitar la frecuencia de la enterocolitis necrotizante del recien nacido.
US4997761A (en) Phosphatidyl treatment of viral disease
GB2216418A (en) Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.
WO1996038137A1 (en) Methods for maintaining or elevating the cd-4 or cd-8 cell levels comprising the administration of conjugated linoleic acid; a new process for the manufacture of conjugated linoleic acid using lactobacillus sp
SE522246C2 (sv) Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
ES2228057T3 (es) Oregano para el tratamiento de parasitos internos y protozoos.
RS49831B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
KR101263963B1 (ko) 항바이러스 및 면역자극 해산 어류 오일 조성물
RS57199B1 (sr) Ekstrakti kakaa, proizvodi od kakaa i postupci za njihovu proizvodnju
KR890000096A (ko) 비경구투여용 약제학적 조성물
ME00530B (me) Farmaceutske kompozicije tizoksanida i nitazoksanida
JPH01265023A (ja) 下痢症ウイルス感染阻害剤
KR101717280B1 (ko) 게르마늄의 착체 화합물, 이를 제조하는 방법, 및 약물
US5466714A (en) Spermicidal and cytocidal fatty acid compositions
RU2182828C1 (ru) Композиция, обладающая антивич и антигерпесной активностью
Zahid et al. Effect of chloroquine on liver weight of developing albino rats
CA2085799A1 (en) Compositions for the treatment of mammalian diseases
HK1113910A (en) Antiviral and immunostimulating marine fish oil composition
JPH0748279A (ja) 後天性免疫不全症候群の治療法
US5840711A (en) Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
Emoto et al. Biological Functions of Mouse Seminal Vesicle Fluid I. Suppression of Blastogenic Responses of Lymphocytes

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20160415

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20170412

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20190425

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20230508

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230508